Stryker Corporation (SYK)

Operating return on assets (Operating ROA)

Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Operating income (ttm) US$ in thousands 5,636,000 5,338,000 5,411,000 5,208,000 5,032,000 4,794,000 4,577,000 4,483,000 4,338,000 4,108,000 3,966,000 3,808,000 3,734,000 3,629,000 3,676,000 3,707,000 3,651,000 3,657,000 3,680,000 2,951,000
Total assets US$ in thousands 47,844,000 47,057,000 46,331,000 46,006,000 42,971,000 43,833,000 39,130,000 39,402,000 39,912,000 38,042,000 37,409,000 36,830,000 36,884,000 35,983,000 36,032,000 36,137,000 34,631,000 34,145,000 33,698,000 33,455,000
Operating ROA 11.78% 11.34% 11.68% 11.32% 11.71% 10.94% 11.70% 11.38% 10.87% 10.80% 10.60% 10.34% 10.12% 10.09% 10.20% 10.26% 10.54% 10.71% 10.92% 8.82%

December 31, 2025 calculation

Operating ROA = Operating income (ttm) ÷ Total assets
= $5,636,000K ÷ $47,844,000K
= 11.78%


Peer comparison

Dec 31, 2025

Company name
Symbol
Operating ROA
Stryker Corporation
SYK
11.78%
Abbott Laboratories
ABT
9.25%
CONMED Corporation
CNMD
5.10%